Related Experiment Video

Updated: Apr 1, 2026

Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
08:05

Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia

Published on: December 19, 2020

14.9K

Clinical Attributes and Outcomes of Covid-19 Patients

P K Banik1, R Roy, F Ahmed

  • 1Dr Protik Kumar Banik, OSD (6th Grade), Directorate General of Health Services (DGHS), Mohakhali, Dhaka-1212, Bangladesh;

Mymensingh Medical Journal : MMJ
|March 31, 2026
PubMed

Insights

This study found that most COVID-19 patients in Bangladesh experienced no significant functional limitations seven months after illness. Comorbidities and clinical factors were associated with functional status, highlighting the need for continued monitoring.

Area of Science:

  • Infectious Diseases
  • Public Health
  • Epidemiology

Background:

  • The COVID-19 pandemic, caused by SARS-CoV-2, was declared by the WHO in March 2020.
  • Limited data existed on clinical characteristics and outcomes of COVID-19 patients in developing nations during the pandemic's early stages.
  • Bangladesh, a developing country, faced challenges in understanding the disease's impact on its population.

Purpose of the Study:

  • To investigate the clinical attributes of COVID-19 patients in Bangladesh.
  • To assess the post-illness functional status of Bangladeshi COVID-19 survivors.
  • To identify factors associated with functional outcomes in COVID-19 patients in Bangladesh.

Main Methods:

  • A cross-sectional study conducted in 2020 involving 124 COVID-19 positive patients in Dhaka, Bangladesh.
  • Data collected via telephone interviews using a semi-structured questionnaire.
  • Functional status assessed using the Post-COVID-19 Functional Status Scale (Version 2) approximately seven months post-illness.

Main Results:

  • The predominant symptoms were fever (54.0%) and cough (33.1%).
  • 32.3% of patients had comorbidities, with hypertension being the most common (20.2%).
  • Seven months post-illness, 69.4% had no functional limitations, 25.0% had negligible limitations, and 2.4% died.

Conclusions:

  • Approximately two-thirds of COVID-19 patients in Bangladesh recovered with no significant functional limitations.
  • Functional status was significantly associated with the number of comorbidities, age, symptom presence, and treatment location.
  • Recommendations include regular follow-ups and multicenter studies to enhance understanding of COVID-19's long-term effects.

More Related Videos

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses03:53

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses

Published on: November 10, 2023

2.2K
COVID-19 Seroprevalence Test for IgG Antibody Levels Among Healthy Donors Across Different Pandemic Phases in Jeddah04:43

COVID-19 Seroprevalence Test for IgG Antibody Levels Among Healthy Donors Across Different Pandemic Phases in Jeddah

Published on: June 24, 2025

603

Related Concept Videos

COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
2.2K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.2K
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
4.1K
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
1.5K
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.5K
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
727